Data as of Dec 18
| -0.015 / -0.24%|
The 6 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 9.75, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +58.41% increase from the last price of 6.16.
The current consensus among 6 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.